Clin2
NCT07210515Possibly a fitRecruiting

Testing Ambros Therapy for Early CRPS

Complex Regional Pain Syndrome Type I

Part of Brain & nervous system, Pain clinical trials.

This trial tests if an intravenous medicine called AMBTX-01 (neridronate) can help people with early-stage Complex Regional Pain Syndrome (CRPS) type 1. It focuses on those whose affected limb feels warm, looks red, and is swollen.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
270 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are at least 18 years old.
  • You have been diagnosed with CRPS type 1 in one arm or leg (not both) within the last 6 months.
  • Your affected limb is warm, swollen, and looks redder than the other limb.
  • You have not used certain bone medications (like bisphosphonates) or ketamine in the past 6 to 12 months.
  • You are not pregnant, breastfeeding, or planning to become pregnant during the study.
  • You do not have severe kidney problems, low calcium, low vitamin D, or active dental issues.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06306157Enrolling by invitation· Phase 4
Low dose naltrexone for complex regional pain syndrome

This trial tests whether a low dose of naltrexone, a medication that may help calm overactive immune and pain signals, can reduce pain and improve daily life in people with complex regional pain syndrome (CRPS), a chronic condition that often causes severe pain and swelling.

New York, New York
NCT07711392Not yet recruiting
Vagus nerve stimulation for complex regional pain syndrome

This trial tests whether adding a gentle, non-invasive nerve stimulation (like a small electrical pulse on your ear) to standard rehabilitation can help reduce pain and improve function in people with complex regional pain syndrome (CRPS) affecting the hand. It aims to see if this extra treatment offers more relief than rehabilitation alone.

NCT05052736Recruiting
Noninvasive brain/nerve stimulation for early CRPS type I

This trial studies a noninvasive stimulation treatment to help people with early-stage complex regional pain syndrome (CRPS) type I. It may help calm nerve-related pain, especially soon after symptoms begin.

Las Palmas de Gran Canaria, Palmas, Las
NCT07473635Recruiting
Botox injections for nerve pain in CRPS — an early safety study

This study tests whether a specially targeted injection of botulinum toxin (like Botox) around nerves can help reduce pain from CRPS. It aims to see if the treatment is safe and doable for people with long-lasting CRPS.

Glostrup, Region Sjælland
NCT07744269Recruiting
Hand therapy for early complex regional pain syndrome

This trial compares two hand therapy techniques — contrast baths (alternating warm and cool water) and compression with whirlpool therapy — to see which better eases early-stage complex regional pain syndrome (CRPS) after a hand or wrist injury. If you've had hand or wrist trauma and are still in pain, this study might help you find a treatment that reduces discomfort and improves hand use.

Ankara, Yenimahalle
NCT07208825Recruiting
Conservative care for complex regional pain syndrome

This study tests whether a conservative treatment plan can help people with complex regional pain syndrome (CRPS), a condition where pain lasts longer than expected after an injury. You may qualify if you have had CRPS symptoms for up to 5 years and are between ages 18 and 70.

Oulu, North Ostrobothnia

Hear when a new Complex Regional Pain Syndrome Type I trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.